LifeStance (LFST) Soars 30% on Q3 Earnings Blowout

Core Insights - LifeStance Health Group, Inc. (NASDAQ:LFST) experienced a significant stock recovery, rising by 29.94% to close at $6.25, driven by strong third-quarter earnings performance [1] Financial Performance - The company reported a net income of $1.077 million, a turnaround from a net loss of $5.9 million in the same quarter last year, indicating a positive shift in financial health [2] - Total revenues for the quarter increased by 16% to $363.8 million, up from $312.7 million year-on-year [2] - For the nine-month period, net loss decreased by 96% to $2 million from $50.3 million in the previous year, showcasing a substantial recovery [3] - Total revenues for the nine months reached $1.04 billion, reflecting a 12.6% increase from $925 million year-on-year [3] Future Outlook - The CEO of LifeStance highlighted that the quarter was record-breaking and indicated improved operating leverage, leading to an increase in full-year Adjusted EBITDA guidance [4] - The company maintained its revenue growth outlook for 2025, projecting revenues between $1.41 billion and $1.43 billion, and raised adjusted EBITDA expectations to a range of $146 million to $152 million [4] - For the fourth quarter, revenues are targeted between $368 million and $388 million, with adjusted EBITDA projected at $37 million to $43 million [5]